JP2010540461A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540461A5 JP2010540461A5 JP2010526063A JP2010526063A JP2010540461A5 JP 2010540461 A5 JP2010540461 A5 JP 2010540461A5 JP 2010526063 A JP2010526063 A JP 2010526063A JP 2010526063 A JP2010526063 A JP 2010526063A JP 2010540461 A5 JP2010540461 A5 JP 2010540461A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hydroxytryptophan
- amount
- ylsulfanyl
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 24
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 claims 9
- 229940000681 5-hydroxytryptophan Drugs 0.000 claims 9
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 claims 9
- DSPWBIJQOFBHOC-UHFFFAOYSA-N 1-[2-[(6-fluoro-1h-indol-3-yl)sulfanyl]phenyl]-n-methylmethanamine Chemical compound CNCC1=CC=CC=C1SC1=CNC2=CC(F)=CC=C12 DSPWBIJQOFBHOC-UHFFFAOYSA-N 0.000 claims 5
- 229960004205 carbidopa Drugs 0.000 claims 2
- TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical group NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 claims 2
- 238000006114 decarboxylation reaction Methods 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- -1 [2- (6- fluoro -1H- indol-3-ylsulfanyl) - benzyl] - methyl Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97459507P | 2007-09-24 | 2007-09-24 | |
| PCT/US2008/077435 WO2009042632A2 (en) | 2007-09-24 | 2008-09-24 | Combination therapy related to serotonin dual action compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540461A JP2010540461A (ja) | 2010-12-24 |
| JP2010540461A5 true JP2010540461A5 (OSRAM) | 2011-11-10 |
Family
ID=40512095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010526063A Pending JP2010540461A (ja) | 2007-09-24 | 2008-09-24 | セロトニン二重作用化合物に関する併用療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100286226A1 (OSRAM) |
| EP (1) | EP2205238A4 (OSRAM) |
| JP (1) | JP2010540461A (OSRAM) |
| CN (1) | CN101868233A (OSRAM) |
| CA (1) | CA2700199A1 (OSRAM) |
| WO (1) | WO2009042632A2 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007107165A1 (en) * | 2006-03-22 | 2007-09-27 | H. Lundbeck A/S | Method for identifying compounds for the treatment of depression |
| WO2012054815A1 (en) | 2010-10-22 | 2012-04-26 | Duke University | Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
| US11464756B1 (en) | 2017-05-19 | 2022-10-11 | Jerry Darm | Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof |
| US12409163B2 (en) | 2021-07-30 | 2025-09-09 | Evecxia Therapeutics, Inc. | Method of enhancing 5-hydroxytryptophan (5-HTP) exposure |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932652A (en) * | 1972-06-30 | 1976-01-13 | Hoffmann-La Roche Inc. | Antidepressant compositions |
| US4329356A (en) * | 1980-10-31 | 1982-05-11 | Eli Lilly And Company | Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane |
| US4413012A (en) * | 1981-06-01 | 1983-11-01 | Merrell Toraude Et Compagnie | Method for treating depression |
| US4596807A (en) * | 1985-03-26 | 1986-06-24 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
| US4698342A (en) * | 1985-07-16 | 1987-10-06 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| US5958429A (en) * | 1996-08-16 | 1999-09-28 | Eli Lilly And Company | Potentiation of serotonin response |
| US6207699B1 (en) * | 1999-06-18 | 2001-03-27 | Richard Brian Rothman | Pharmaceutical combinations for treating obesity and food craving |
| US6403657B1 (en) * | 1999-10-04 | 2002-06-11 | Martin C. Hinz | Comprehensive pharmacologic therapy for treatment of obesity |
| US20020147153A1 (en) * | 2001-02-14 | 2002-10-10 | Functional Foods, Inc. | Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin |
| US20040197377A1 (en) * | 2003-04-03 | 2004-10-07 | Thompson Marshall Anlauf | 5-HTP composition |
| JP4090491B2 (ja) * | 2003-12-23 | 2008-05-28 | ハー・ルンドベック・アクチエゼルスカベット | ２−（１ｈ−インドリルスルファニル）−ベンジルアミン誘導体 |
| WO2005112906A2 (en) * | 2004-05-21 | 2005-12-01 | Duke University | Method for augmenting the effects of serotonin reuptake inhibitors |
| AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
| US20070117844A1 (en) * | 2005-11-18 | 2007-05-24 | Morillo Connie S | 5-HTP combination therapy |
| US20070213370A1 (en) * | 2005-11-18 | 2007-09-13 | H. Lundbeck A/S | 5-HTP Combination Therapy |
| WO2007107165A1 (en) * | 2006-03-22 | 2007-09-27 | H. Lundbeck A/S | Method for identifying compounds for the treatment of depression |
-
2008
- 2008-09-24 US US12/679,789 patent/US20100286226A1/en not_active Abandoned
- 2008-09-24 EP EP08833434A patent/EP2205238A4/en not_active Withdrawn
- 2008-09-24 JP JP2010526063A patent/JP2010540461A/ja active Pending
- 2008-09-24 WO PCT/US2008/077435 patent/WO2009042632A2/en not_active Ceased
- 2008-09-24 CN CN200880118145A patent/CN101868233A/zh active Pending
- 2008-09-24 CA CA2700199A patent/CA2700199A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA29115B1 (fr) | Produits pharmaceutiques solides, administres par voie orale et contenant du rivaroxaban, a liberation modifiee | |
| JP2010522208A5 (OSRAM) | ||
| EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2009537554A5 (OSRAM) | ||
| EP2491923A3 (en) | Combinations of therapeutic agents for treating cancer | |
| IL199187A (en) | Indole history, pharmaceuticals including them and their use in the manufacture of medicines | |
| JP2009538276A5 (OSRAM) | ||
| JP2009084294A5 (OSRAM) | ||
| EA201490014A1 (ru) | Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот | |
| JP2010535814A5 (OSRAM) | ||
| CL2007001689A1 (es) | Formas cristalinas sustancialmente puras de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida; composicion farmaceutica, util para tratar una enfermedad que responde a una inhibicion de la actividad de cinasa de prot | |
| ECSP10010562A (es) | Cápsula para la prevención de enfermedades cardiovasculares | |
| AR061298A1 (es) | Sales de n-hidroxi -3- [4- [ [ [2- (2-metil-1h-indol-3-il) etil] amino] metil] fenil] -2e-2- propenamida.composciones farmaceuticas. | |
| JP2010540461A5 (OSRAM) | ||
| JP2008531742A5 (OSRAM) | ||
| DE602008006243D1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
| JP2005527551A5 (OSRAM) | ||
| JP2007510714A5 (OSRAM) | ||
| JP2009263366A5 (OSRAM) | ||
| JP2011068692A5 (OSRAM) | ||
| JP2006516141A5 (OSRAM) | ||
| JP2008515980A5 (OSRAM) | ||
| TR201001417A1 (tr) | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu | |
| UA94251C2 (ru) | Индолпроизводная соль лимонной кислоты и ее фармацевтическое применение | |
| TW200700062A (en) | Pharmaceutical compositions |